Vitamin E Deficiency and Neurologic Disease in Adults with Cystic Fibrosis

  1. MICHAEL D. SITRIN, M.D.;
  2. FRANK LIEBERMAN, M.D.;
  3. WESLEY E. JENSEN, Ph.D.;
  4. AVERTANO NORONHA, M.D.;
  5. CAROL MILBURN, R.N.; and
  6. WHITNEY ADDINGTON, M.D.
  1. Chicago, Illinois

    Abstract

    We report the cases of two adult patients with cystic fibrosis affecting the pancreas and liver, who also had severe vitamin E deficiency and neurologic disease. The most prominent clinical features were abnormal eye movements, diminished reflexes, decreased vibratory and position sense, ataxia, and muscle weakness. Treatment with intramuscular injections of vitamin E partially corrected the neurologic deficits. Vitamin E absorption tests documented severe malabsorption, which was later alleviated by the addition of dessicated ox bile to the regimen of alpha-tocopheryl acetate. These studies suggest that a decreased intraluminal concentration of bile salts is an important factor in the development of severe vitamin E deficiency and in the poor response to oral replacement therapy that is seen in some patients with cystic fibrosis.

    Article and Author Information

    • ▸From the Departments of Medicine and Neurology and Clinical Nutrition Research Unit, Pritzker School of Medicine, University of Chicago; Chicago, Illinois.

    • ▸Requests for reprints should be addressed to Michael D. Sitrin, M.D.; The University of Chicago, 5841 S. Maryland, Box 223; Chicago, IL 60637.

    « Previous | Next Article »Table of Contents